US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 0.4510
  • -0.0189-4.02%
Close May 21 16:00 ET
  • 0.4510
  • 0.00000.00%
Post 16:01 ET
3.88MMarket Cap-246P/E (TTM)

Evoke Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
81.32%-1.1M
9.06%-1.37M
Net income from continuing operations
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
-2.26%-2.01M
2.50%-2.23M
Other non cash items
-22.56%124.66K
248.61%129.07K
-45.64%13.37K
--39.47K
---84.73K
--160.96K
135.22%37.03K
--24.6K
----
----
Change In working capital
-927.09%-1.38M
1,070.72%1.55M
154.15%586.29K
-39.23%331.07K
-5.40%466.14K
-6.16%166.64K
102.36%132.41K
-33.82%-1.08M
112.42%544.76K
29.42%492.75K
-Change in receivables
-1,146.73%-778.83K
85.37%-48.24K
1,018.58%560.83K
32.08%-210.09K
-731.74%-336.51K
49.51%-62.47K
-21.24%-329.64K
168.66%50.14K
-1,202.16%-309.33K
175.43%53.27K
-Change in inventory
-41.66%-106.94K
-85.34%-192.46K
----
----
----
---75.49K
-595.77%-103.84K
----
----
----
-Change in prepaid assets
-21.14%222.05K
209.33%31.93K
36.71%-581.08K
-25.55%255.74K
-76.22%75.7K
23.98%281.57K
-118.53%-29.21K
-2.21%-918.18K
-2.42%343.52K
-7.52%318.36K
-Change in payables and accrued expense
36.56%343.6K
106.17%1.16M
702.10%318.02K
-67.68%108.16K
10,143.11%477.33K
38.78%251.61K
111.14%560.28K
-90.84%39.65K
106.82%334.67K
106.09%4.66K
-Change in other current liabilities
--0
-248.61%-129.07K
45.64%-13.37K
-217.61%-39.47K
---38.56K
---37.68K
---37.03K
---24.6K
---12.43K
--0
-Change in other working capital
-454.26%-1.06M
920.12%732.85K
492.85%494.34K
15.08%216.74K
82.61%212.68K
-78.22%-190.91K
114.46%71.84K
56.83%-125.84K
-0.52%188.33K
-36.58%116.47K
Cash from discontinued investing activities
Operating cash flow
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
81.32%-1.1M
9.06%-1.37M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
7.54M
-101.64%-119.3K
-119.3K
0
0
0
-45.68%7.29M
0
0
15,571.79%7.12M
Net common stock issuance
--6.72M
--0
--0
--0
--0
--0
-49.34%7.44M
2,220.40%148.99K
-147.59%-148.99K
457.34%7.27M
Proceeds from stock option exercised by employees
--1.25M
----
----
----
----
--0
----
----
----
----
Net other financing activities
---426.29K
19.93%-119.3K
----
----
----
----
88.64%-148.99K
----
----
----
Cash from discontinued financing activities
Financing cash flow
--7.54M
-101.64%-119.3K
---119.3K
--0
--0
--0
-45.68%7.29M
--0
--0
15,571.79%7.12M
Net cash flow
Beginning cash position
-51.85%4.74M
7.64%9.84M
-51.70%5.96M
-47.91%7.01M
6.64%8.21M
7.64%9.84M
13.33%9.14M
10.84%12.35M
-19.56%13.45M
-57.65%7.7M
Current changes in cash
404.33%4.96M
-830.24%-5.1M
51.11%-1.23M
5.39%-1.04M
-120.98%-1.21M
-12.98%-1.63M
-35.02%698.99K
-25.49%-2.51M
80.27%-1.1M
492.46%5.75M
End cash Position
18.14%9.7M
-51.85%4.74M
-51.85%4.74M
-51.70%5.96M
-47.91%7.01M
6.64%8.21M
7.64%9.84M
7.64%9.84M
10.84%12.35M
-19.56%13.45M
Free cash flow
-58.16%-2.58M
24.42%-4.98M
55.87%-1.11M
5.39%-1.04M
12.18%-1.21M
-0.98%-1.63M
46.60%-6.6M
-25.49%-2.51M
81.32%-1.1M
9.06%-1.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M81.32%-1.1M9.06%-1.37M
Net income from continuing operations 29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M-2.26%-2.01M2.50%-2.23M
Other non cash items -22.56%124.66K248.61%129.07K-45.64%13.37K--39.47K---84.73K--160.96K135.22%37.03K--24.6K--------
Change In working capital -927.09%-1.38M1,070.72%1.55M154.15%586.29K-39.23%331.07K-5.40%466.14K-6.16%166.64K102.36%132.41K-33.82%-1.08M112.42%544.76K29.42%492.75K
-Change in receivables -1,146.73%-778.83K85.37%-48.24K1,018.58%560.83K32.08%-210.09K-731.74%-336.51K49.51%-62.47K-21.24%-329.64K168.66%50.14K-1,202.16%-309.33K175.43%53.27K
-Change in inventory -41.66%-106.94K-85.34%-192.46K---------------75.49K-595.77%-103.84K------------
-Change in prepaid assets -21.14%222.05K209.33%31.93K36.71%-581.08K-25.55%255.74K-76.22%75.7K23.98%281.57K-118.53%-29.21K-2.21%-918.18K-2.42%343.52K-7.52%318.36K
-Change in payables and accrued expense 36.56%343.6K106.17%1.16M702.10%318.02K-67.68%108.16K10,143.11%477.33K38.78%251.61K111.14%560.28K-90.84%39.65K106.82%334.67K106.09%4.66K
-Change in other current liabilities --0-248.61%-129.07K45.64%-13.37K-217.61%-39.47K---38.56K---37.68K---37.03K---24.6K---12.43K--0
-Change in other working capital -454.26%-1.06M920.12%732.85K492.85%494.34K15.08%216.74K82.61%212.68K-78.22%-190.91K114.46%71.84K56.83%-125.84K-0.52%188.33K-36.58%116.47K
Cash from discontinued investing activities
Operating cash flow -58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M81.32%-1.1M9.06%-1.37M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 7.54M-101.64%-119.3K-119.3K000-45.68%7.29M0015,571.79%7.12M
Net common stock issuance --6.72M--0--0--0--0--0-49.34%7.44M2,220.40%148.99K-147.59%-148.99K457.34%7.27M
Proceeds from stock option exercised by employees --1.25M------------------0----------------
Net other financing activities ---426.29K19.93%-119.3K----------------88.64%-148.99K------------
Cash from discontinued financing activities
Financing cash flow --7.54M-101.64%-119.3K---119.3K--0--0--0-45.68%7.29M--0--015,571.79%7.12M
Net cash flow
Beginning cash position -51.85%4.74M7.64%9.84M-51.70%5.96M-47.91%7.01M6.64%8.21M7.64%9.84M13.33%9.14M10.84%12.35M-19.56%13.45M-57.65%7.7M
Current changes in cash 404.33%4.96M-830.24%-5.1M51.11%-1.23M5.39%-1.04M-120.98%-1.21M-12.98%-1.63M-35.02%698.99K-25.49%-2.51M80.27%-1.1M492.46%5.75M
End cash Position 18.14%9.7M-51.85%4.74M-51.85%4.74M-51.70%5.96M-47.91%7.01M6.64%8.21M7.64%9.84M7.64%9.84M10.84%12.35M-19.56%13.45M
Free cash flow -58.16%-2.58M24.42%-4.98M55.87%-1.11M5.39%-1.04M12.18%-1.21M-0.98%-1.63M46.60%-6.6M-25.49%-2.51M81.32%-1.1M9.06%-1.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg